C
Harmony Biosciences Holdings, Inc. HRMY
$38.05 $0.882.37% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 180.90M 152.72M 145.49M 122.63M 114.99M
Total Depreciation and Amortization 23.87M 23.96M 24.11M 24.27M 24.41M
Total Amortization of Deferred Charges 673.00K 686.00K 700.00K 716.00K 1.79M
Total Other Non-Cash Items 38.77M 58.16M 56.84M 64.81M 68.80M
Change in Net Operating Assets 15.16M -12.86M -7.32M 8.51M 3.53M
Cash from Operations 259.38M 222.67M 219.82M 220.92M 213.52M
Capital Expenditure -648.00K -1.28M -1.15M -747.00K -744.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 0.00 -33.07M -33.07M -70.04M -70.04M
Divestitures -- -- -- -- --
Other Investing Activities -23.02M -24.59M -33.26M -25.58M -27.14M
Cash from Investing -23.67M -58.94M -67.48M -96.36M -97.92M
Total Debt Issued -- -- -- 0.00 200.00M
Total Debt Repaid -15.00M -15.00M -15.00M -15.00M -207.75M
Issuance of Common Stock 12.62M 11.09M 6.50M 3.49M 1.16M
Repurchase of Common Stock -4.57M -3.81M -2.50M -50.27M -100.27M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 0.00 -8.84M
Cash from Financing -6.95M -7.71M -11.00M -61.78M -115.70M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 228.75M 156.02M 141.34M 62.78M -99.00K